Florentia Kaguelidou

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Postoperative Pain

Top Venues

Pediatric diabetes

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Estelle Ayme-Dietrich, Florentia Kaguelidou, Gilles Bertschy, Laurent Chouchana
Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiology and drug safety 33 (6) (2024)
Florentia Kaguelidou, Zaba Valtuille, Geneviève Durrieu, Richard Delorme, Hugo Peyre, Jean-Marc Treluyer, François Montastruc, Laurent Chouchana
Weight Gain During Antipsychotic Treatment in Children, Adolescents, and Adults: A Disproportionality Analysis in the Global Pharmacovigilance Database, Vigibase ® . Drug safety (2022)
Florentia Kaguelidou, Jakob Holstiege, Tania Schink, Irene Bezemer, Elisabetta Poluzzi, Giampiero Mazzaglia, Lars Pedersen, Miriam Sturkenboom, Gianluca Trifirò
'Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study'. Epidemiology and psychiatric sciences 29 (2020)
Florentia Kaguelidou, Enora Le Roux, Laura Mangiarini, Rebecca Lundin, Thomas G de Leeuw, Oscar Della Pasqua, Mariagrazia Felisi, Donato Bonifazi, Dick Tibboel, Adriana Ceci, Saskia N de Wildt, Corinne Alberti, null null
Non-inferiority double-blind randomised controlled trial comparing gabapentin versus tramadol for the treatment of chronic neuropathic or mixed pain in children and adolescents: the GABA-1 trial-a study protocol. BMJ open 9 (2) (2019)
Sophie Guilmin-Crépon, Jean-Claude Carel, Julien Schroedt, Véronique Sulmont, Anne-Sophie Salmon, Claire Le Tallec, Régis Coutant, Fabienne Dalla-Vale, Chantal Stuckens, Hélène Bony-Trifunovic, Hélène Crosnier, François Kurtz, Florentia Kaguelidou, Anaïs Le Jeannic, Isabelle Durand-Zaleski, Nathalie Couque, Corinne Alberti, Nadia Tubiana-Rufi
Is there an optimal strategy for real-time continuous glucose monitoring in pediatrics? A 12-month French multi-center, prospective, controlled randomized trial (Start-In!). Pediatric diabetes 20 (3) (2019)